Valuation: Sight Sciences, Inc.

Market Cap 479M 428M 395M 359M 673M 45.4B 683M 4.75B 1.87B 23.78B 1.8B 1.76B 75.35B P/E 2026 *
-15.4x
P/E 2027 * -20.1x
Enterprise Value 442M 394M 364M 330M 620M 41.82B 629M 4.38B 1.73B 21.91B 1.66B 1.62B 69.42B EV / Sales 2026 *
4.89x
EV / Sales 2027 * 4.47x
Free-Float
80.19%
Yield 2026 *
-
Yield 2027 * -
1 day+4.48%
1 week+10.18%
Current month-2.88%
1 month+7.07%
3 months+85.13%
6 months+113.88%
Current year+14.63%
1 week 8.09
Extreme 8.09
9.1
1 month 7.84
Extreme 7.84
9.71
Current year 3.38
Extreme 3.378
9.71
1 year 3.38
Extreme 3.378
9.71
3 years 1.04
Extreme 1.04
9.71
5 years 1.04
Extreme 1.04
27.7
10 years 1.04
Extreme 1.04
42.57
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 56 01/01/2010
Chief Executive Officer 51 01/01/2010
Director of Finance/CFO 43 05/11/2025
Director TitleAgeSince
Director/Board Member 51 01/01/2010
Director/Board Member 56 01/01/2010
Chairman 74 01/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
02/10/26 Sell

Chief Operating Officer

-25,260 0.0459%
02/10/26 Sell

Chief Financial Officer

-7,208 0.0131%
02/10/26 Sell

Executive/Senior Manager

-2,988 0.0054%
Change 5-day change 1-year change 3-year change Capi.($)
+4.48%+10.18%+76.16%+147.01% 479M
+1.99%-2.07%-19.88%+7.03% 174B
+3.19%+4.72%-20.93%+16.51% 114B
+3.83%+1.19%+0.72%+33.43% 114B
+1.93%+19.62%-44.05%+8.64% 89.64B
-0.57%-0.86%+2.32%+79.26% 64.96B
-0.47%+3.86%+15.10%+80.50% 56.09B
+3.13%+3.44%+6.54%-21.69% 52.94B
+2.40%+7.14%-11.04%+32.73% 43.6B
+3.43%+8.36%-4.02%-10.63% 32.77B
Average +2.25%+4.98%+0.09%+37.28% 74.24B
Weighted average by Cap. +2.04%+3.58%-12.05%+23.37%

Financials

2026 *2027 *
Net sales 90.32M 80.62M 74.38M 67.57M 127M 8.56B 129M 896M 353M 4.48B 339M 332M 14.2B 101M 90.11M 83.14M 75.53M 142M 9.56B 144M 1B 395M 5.01B 379M 371M 15.87B
Net income -31.94M -28.51M -26.3M -23.9M -44.83M -3.03B -45.52M -317M -125M -1.59B -120M -117M -5.02B -26.04M -23.24M -21.44M -19.48M -36.55M -2.47B -37.11M -258M -102M -1.29B -97.75M -95.66M -4.09B
Net Debt -37.73M -33.68M -31.07M -28.23M -52.96M -3.57B -53.77M -374M -147M -1.87B -142M -139M -5.93B -27.73M -24.75M -22.84M -20.75M -38.92M -2.63B -39.52M -275M -108M -1.38B -104M -102M -4.36B
Projected Income Statement - Annual - Sight Sciences, Inc.
Logo Sight Sciences, Inc.
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Employees
186
Date Price Change Volume
23/10/26 $9.090 +4.48% 225,088
21/10/26 $8.700 +0.93% 154,709
20/10/26 $8.620 +4.36% 258,548
19/10/26 $8.260 -0.24% 186,108
16/10/26 $8.280 -5.91% 289,298
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Sight Sciences, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
8.700USD
Average target price
10.17USD
Spread / Average Target
+16.86%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sight Sciences, Inc.
  1. Stock Market
  2. Stocks
  3. SGHT Stock